Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hernández, José Mariano
Monitor- ACS, NCT03940066: Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile	Active, not recruiting	N/A	169	Europe	Biomonitor-2 and Kardia mobile, No Intervention	Fundación EPIC	Atrial Fibrillation, Syncope, Tachycardia, Arrhythmias, Cardiac, Heart Diseases	06/23	06/23
NCT05887700: Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up	Recruiting	N/A	145	Europe, RoW	CeraFlex™ Atrial Septal Defect (ASD) Closure System	Lifetech Scientific (Shenzhen) Co., Ltd.	Atrial Septal Defect	12/24	12/24
TRANSFORM II, NCT04893291: Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels	Recruiting	N/A	1820	Europe, RoW	Everolimus Eluting Stent, Sirolimus Coated Balloon	Fondazione Ricerca e Innovazione Cardiovascolare ETS	Coronary Artery Disease, Coronary Artery Stenosis	11/24	11/28
NCT03613246: NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population	Recruiting	N/A	200	Europe		NVT GmbH	Transcatheter Aortic Valve Implantation	12/24	02/25
FastTRACK, NCT02659215: HyaloFAST Trial for Repair of Articular Cartilage in the Knee	Active, not recruiting	N/A	200	Europe, US, RoW	Hyalofast, Microfracture	Anika Therapeutics, Inc.	Defect of Articular Cartilage	06/25	06/26
PETHEMA LAL-2019, NCT04179929: Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults	Recruiting	N/A	300	Europe	Pediatric-type of chemotherapy, allogeneic HSCT	PETHEMA Foundation	Acute Lymphoblastic Leukemia	11/26	02/27